zantac 150 mg/10 ml siroop
glaxosmithkline pharmaceuticals sa-nv - ranitidinehydrochloride 16,8 mg/ml - eq. ranitidine 15 mg/ml - siroop - 150 mg/10 ml - ranitidinehydrochloride 16.8 mg/ml - ranitidine
zantac 150 mg filmomh. tabl.
glaxosmithkline pharmaceuticals sa-nv - ranitidinehydrochloride 168 mg - eq. ranitidine 150 mg - filmomhulde tablet - 150 mg - ranitidinehydrochloride 168 mg - ranitidine
zantac 150 mg bruistabl.
glaxosmithkline pharmaceuticals sa-nv - ranitidinehydrochloride 168 mg - eq. ranitidine 150 mg - bruistablet - 150 mg - ranitidinehydrochloride 168 mg - ranitidine
zantac 300 mg bruistabl.
glaxosmithkline pharmaceuticals sa-nv - ranitidinehydrochloride 336 mg - eq. ranitidine 300 mg - bruistablet - 300 mg - ranitidinehydrochloride 336 mg - ranitidine
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastische middelen - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
diphantoïne 100 mg tabl.
kela pharma sa-nv - fenytoïnenatrium 100 mg - tablet - phenytoin
ranitidine mylan 150 mg filmomh. tabl.
viatris gx bv-srl - ranitidinehydrochloride 168 mg - eq. ranitidine 150 mg - filmomhulde tablet - ranitidine
ranitidine mylan 300 mg filmomh. tabl.
viatris gx bv-srl - ranitidinehydrochloride 336 mg - eq. ranitidine 300 mg - filmomhulde tablet - ranitidine
famotidine prolepha 20 mg, filmomhulde tabletten
famotidine 20 mg/stuk - filmomhulde tablet - cellulose, microkristallijn (e 460) ; hypromellose (e 464) ; ijzeroxide geel (e 172) ; ijzeroxide rood (e 172) ; ijzeroxide zwart (e 172) ; magnesiumstearaat (e 470b) ; maÏszetmeel, gepregelatineerd ; polyethyleenglycol (e 1521) ; talk (e 553 b) ; titaandioxide (e 171)
famotidine prolepha 40 mg, filmomhulde tabletten
famotidine 40 mg/stuk - filmomhulde tablet - azorubine aluminium lak (e 122) ; cellulose, microkristallijn (e 460) ; chinolinegeel aluminiumlak (e 104) ; hypromellose (e 464) ; ijzeroxide rood (e 172) ; indigokarmijn aluminiumlak (e 132) ; magnesiumstearaat (e 470b) ; maÏszetmeel, gepregelatineerd ; polyethyleenglycol (e 1521) ; talk (e 553 b) ; titaandioxide (e 171)